Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KP8N
|
|||
| Drug Name |
Flavonoid derivative 7
|
|||
| Synonyms |
PMID26161698-Compound-6
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY IP, Nancy Yuk-Yu IP, Fanny Chui-Fun FU, Wing Yu FU, Guangmiao
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H20O11
|
|||
| Canonical SMILES |
CC1C(C(C(C(O1)OC2=C(C=C(C3=C2OC(=C(C3=O)O)C4=CC=C(C=C4)O)O)O)O)O)O
|
|||
| InChI |
1S/C21H20O11/c1-7-13(25)15(27)17(29)21(30-7)32-19-11(24)6-10(23)12-14(26)16(28)18(31-20(12)19)8-2-4-9(22)5-3-8/h2-7,13,15,17,21-25,27-29H,1H3
|
|||
| InChIKey |
PJZKCQPCHMMPJZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cyclin-dependent kinase 5 (CDK5) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cyclin-dependent kinase 5 (CDK5) | Target's Patent Info | [1] | |
| KEGG Pathway | Axon guidance | |||
| Alzheimer's disease | ||||
| Cocaine addiction | ||||
| NetPath Pathway | EGFR1 Signaling Pathway | |||
| TCR Signaling Pathway | ||||
| Panther Pathway | Axon guidance mediated by semaphorins | |||
| Pathway Interaction Database | Reelin signaling pathway | |||
| Glucocorticoid receptor regulatory network | ||||
| Lissencephaly gene (LIS1) in neuronal migration and development | ||||
| EPHA forward signaling | ||||
| Trk receptor signaling mediated by the MAPK pathway | ||||
| Reactome | DARPP-32 events | |||
| CRMPs in Sema3A signaling | ||||
| Factors involved in megakaryocyte development and platelet production | ||||
| WikiPathways | DNA Damage Response | |||
| BDNF signaling pathway | ||||
| Alzheimers Disease | ||||
| Opioid Signalling | ||||
| Semaphorin interactions | ||||
| Factors involved in megakaryocyte development and platelet production | ||||
| Nicotine Activity on Dopaminergic Neurons | ||||
| miRNA Regulation of DNA Damage Response | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.